These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8726943)

  • 1. Effects of rhDNase on purulent airway secretions in chronic bronchitis.
    Puchelle E; Zahm JM; de Bentzmann S; Grosskopf C; Shak S; Mougel D; Polu JM
    Eur Respir J; 1996 Apr; 9(4):765-9. PubMed ID: 8726943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent in vitro effect of recombinant human DNase on rheological and transport properties of cystic fibrosis respiratory mucus.
    Zahm JM; Girod de Bentzmann S; Deneuville E; Perrot-Minnot C; Dabadie A; Pennaforte F; Roussey M; Shak S; Puchelle E
    Eur Respir J; 1995 Mar; 8(3):381-6. PubMed ID: 7789481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of rhDNase on rheologic properties and transport capacity of mucus in cystic fibrosis].
    Puchelle E; Zahm JM
    Arch Pediatr; 1995 Jul; 2(7):670-3. PubMed ID: 7663658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of cystic fibrosis airway mucus transportability by recombinant human DNase is related to changes in phospholipid profile.
    Zahm JM; Galabert C; Chaffin A; Chazalette JP; Grosskopf C; Puchelle E
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1779-84. PubMed ID: 9620905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved activity of an actin-resistant DNase I variant on the cystic fibrosis airway secretions.
    Zahm JM; Debordeaux C; Maurer C; Hubert D; Dusser D; Bonnet N; Lazarus RA; Puchelle E
    Am J Respir Crit Care Med; 2001 Apr; 163(5):1153-7. PubMed ID: 11316652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved clearability of cystic fibrosis sputum with dextran treatment in vitro.
    Feng W; Garrett H; Speert DP; King M
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):710-4. PubMed ID: 9517580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical and functional properties of airway secretions in cystic fibrosis--therapeutic approaches.
    Puchelle E; de Bentzmann S; Zahm JM
    Respiration; 1995; 62 Suppl 1():2-12. PubMed ID: 7792436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro mucolytic activity of recombinant human deoxyribonuclease on equine tracheobronchial mucus.
    Pietra M; Guglielmini C; Forni M; Cinotti S
    Vet Rec; 2000 Nov; 147(22):627-9. PubMed ID: 11128076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis.
    Shah PL; Scott SF; Knight RA; Marriott C; Ranasinha C; Hodson ME
    Thorax; 1996 Feb; 51(2):119-25. PubMed ID: 8711640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of PEGylation on the mucolytic activity of recombinant human deoxyribonuclease I in cystic fibrosis sputum.
    Guichard MJ; Kinoo D; Aubriot AS; Bauwens N; Gougué J; Vermeulen F; Lebecque P; Leal T; Vanbever R
    Clin Sci (Lond); 2018 Jul; 132(13):1439-1452. PubMed ID: 29871879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I.
    King M; Dasgupta B; Tomkiewicz RP; Brown NE
    Am J Respir Crit Care Med; 1997 Jul; 156(1):173-7. PubMed ID: 9230743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of purulence on ciliary and cough transport in bronchiectasis.
    Tambascio J; de Souza HC; Martinez JA; Afonso JL; Jardim JR; Gastaldi AC
    Respir Care; 2013 Dec; 58(12):2101-6. PubMed ID: 23674811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sputum oscillations and rhDNase in vitro: a combined approach to treat cystic fibrosis lung disease.
    Dasgupta B; Brown NE; King M
    Pediatr Pulmonol; 1998 Oct; 26(4):250-5. PubMed ID: 9811074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a short course of rhDNase on cough and mucociliary clearance in patients with cystic fibrosis.
    Robinson M; Hemming AL; Moriarty C; Eberl S; Bye PT
    Pediatr Pulmonol; 2000 Jul; 30(1):16-24. PubMed ID: 10862158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Criteria for evaluating mucus functions and their disorders in chronic bronchitis.
    Sadoul P; Puchelle E; Girard F
    Ciba Found Symp; 1978; (54):277-95. PubMed ID: 248016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of mucus in cough research.
    Rubin BK
    Lung; 2010 Jan; 188 Suppl 1():S69-72. PubMed ID: 19936981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical and transport properties of sputum from children with idiopathic bronchiectasis.
    Redding GJ; Kishioka C; Martinez P; Rubin BK
    Chest; 2008 Dec; 134(6):1129-1134. PubMed ID: 18753467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of drugs on mucus clearance.
    Houtmeyers E; Gosselink R; Gayan-Ramirez G; Decramer M
    Eur Respir J; 1999 Aug; 14(2):452-67. PubMed ID: 10515429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human DNase (rhDNase) influences phospholipid composition, surface activity, rheology and consecutively clearance indices of cystic fibrosis sputum.
    Griese M; App EM; Duroux A; Burkert A; Schams A
    Pulm Pharmacol Ther; 1997; 10(1):21-7. PubMed ID: 9344829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The frog palate for studying mucus transport velocity and mucociliary frequency.
    Puchelle E; Tournier JM; Petit A; Zahm JM; Lauque D; Vidailhet M; Sadoul P
    Eur J Respir Dis Suppl; 1983; 128 (Pt 1)():293-303. PubMed ID: 6604652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.